Works matching IS 00071048 AND DT 2022 AND VI 198 AND IP 5
Results: 24
Artificial intelligence: Training the trainer.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 805, doi. 10.1111/bjh.18358
- Publication type:
- Article
Liposomal doxorubicin supercharge‐containing front‐line treatment in patients with advanced‐stage diffuse large B‐cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single‐centre phase II study.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 847, doi. 10.1111/bjh.18348
- By:
- Publication type:
- Article
80 years of Clinical Hematology.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 802, doi. 10.1111/bjh.18346
- By:
- Publication type:
- Article
Beta‐thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 903, doi. 10.1111/bjh.18345
- By:
- Publication type:
- Article
Integrating artificial intelligence into haematology training and practice: Opportunities, threats and proposed solutions.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 807, doi. 10.1111/bjh.18343
- By:
- Publication type:
- Article
An eltrombopag‐induced remission of bone‐marrow aplasia accompanied by marked leukoerythroblastosis and splenomegaly.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. e75, doi. 10.1111/bjh.18342
- By:
- Publication type:
- Article
Peripheral‐blood cytopenia, an early indicator of inborn errors of immunity.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 875, doi. 10.1111/bjh.18337
- By:
- Publication type:
- Article
Chimeric antigen receptor T‐cell therapy is superior to standard of care as second‐line therapy for large B‐cell lymphoma: A systematic review and meta‐analysis.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 838, doi. 10.1111/bjh.18335
- By:
- Publication type:
- Article
Sequential loss of B‐cell target antigens in multiply relapsed high‐grade B‐cell lymphoma treated with targeted therapies.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. e71, doi. 10.1111/bjh.18333
- By:
- Publication type:
- Article
Regulatory T cells are replenished in the splenic microenvironment of patients with immune thrombocytopenia by treatment with thrombopoietin receptor agonists.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 803, doi. 10.1111/bjh.18332
- Publication type:
- Article
Antithrombin‐III mitigates thrombin‐mediated endothelial cell contraction and sickle red blood cell adhesion in microscale flow.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 893, doi. 10.1111/bjh.18328
- By:
- Publication type:
- Article
Enhanced stimulation of antigen‐specific immune responses against nucleophosmin 1 mutated acute myeloid leukaemia by an anti‐programmed death 1 antibody.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 866, doi. 10.1111/bjh.18326
- By:
- Publication type:
- Article
Protein‐losing enteropathy in association with gastrointestinal IgM deposition in Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 801, doi. 10.1111/bjh.18325
- By:
- Publication type:
- Article
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 830, doi. 10.1111/bjh.18324
- By:
- Publication type:
- Article
The utility of peripheral blood film and haemolysis markers in evaluation of haemolytic anaemia at a tertiary care hospital.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 927, doi. 10.1111/bjh.18321
- By:
- Publication type:
- Article
Heterozygous, germline JAK2 E846D substitution as the cause of familial erythrocytosis.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 923, doi. 10.1111/bjh.18320
- By:
- Publication type:
- Article
Treatment with obinutuzumab leads to worse outcomes in haematological patients diagnosed with Omicron variant COVID‐19.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 826, doi. 10.1111/bjh.18315
- By:
- Publication type:
- Article
Blinatumomab as bridging therapy in paediatric B‐cell acute lymphoblastic leukaemia complicated by invasive fungal disease.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 887, doi. 10.1111/bjh.18314
- By:
- Publication type:
- Article
Thrombopoietin receptor agonists increase splenic regulatory T‐cell numbers in immune thrombocytopenia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 916, doi. 10.1111/bjh.18309
- By:
- Publication type:
- Article
Unanswered questions in cancer‐associated thrombosis.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 812, doi. 10.1111/bjh.18276
- By:
- Publication type:
- Article
BLOOD CELLS – A PRACTICAL GUIDE.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 930, doi. 10.1111/bjh.18236
- Publication type:
- Article
Prevalence of plasma cell and lymphoproliferative disorders among blood relatives of patients with light chain amyloidosis.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 861, doi. 10.1111/bjh.18225
- By:
- Publication type:
- Article
Changing trends of splenectomy in hereditary spherocytosis: The experience of a reference Centre in the last 40 years.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 912, doi. 10.1111/bjh.18106
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 797, doi. 10.1111/bjh.17599
- Publication type:
- Article